AlphaCentric Advisors’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

AlphaCentric Advisors’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-98,500	Closed	-$1.17M	–	285
2021 Q3	$1.17M	Buy	98,500 +62,000	+170%	+$903K	0.3%	19
2021 Q2	$627K	Buy	36,500 +14,500	+66%	+$276K	0.17%	51
2021 Q1	$402K	Buy	22,000 +10,000	+83%	+$210K	0.14%	56
2020 Q4	$226K	Buy	+12,000	New	+$259K	0.09%	60

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

AlphaCentric Advisors's OYST Position: Q4 2021 in Review

AlphaCentric Advisors sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2021, closing a stake of 98,500 shares — an estimated $1.17M sold.

AlphaCentric Advisors first reported a position in OYST in Q4 2020 and held it in 4 quarters. The position peaked at $1.17M in Q3 2021. 80 funds tracked by Wall St. Rank hold OYST as of Q4 2021.

AlphaCentric Advisors reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
AlphaCentric Advisors sold 98,500 Oyster Point Pharma, Inc. Common Stock shares in Q4 2021, an estimated $1.17M.
AlphaCentric Advisors first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
AlphaCentric Advisors's Oyster Point Pharma, Inc. Common Stock position peaked at $1.17M in Q3 2021.
80 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2021.

Based on AlphaCentric Advisors's 13F filing for Q4 2021, filed 25 Feb 2022.